Baird Financial Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,434
| Closed | -$447K | – | 1949 |
|
|
2021
Q2 | $447K | Sell |
2,434
-120
| -5% | -$22K | ﹤0.01% | 1436 |
|
|
2021
Q1 | $391K | Sell |
2,554
-845
| -25% | -$129K | ﹤0.01% | 1427 |
|
|
2020
Q4 | $531K | Sell |
3,399
-62
| -2% | -$9.69K | ﹤0.01% | 1217 |
|
|
2020
Q3 | $396K | Sell |
3,461
-5
| -0.1% | -$572 | ﹤0.01% | 1230 |
|
|
2020
Q2 | $389K | Sell |
3,466
-241
| -7% | -$27K | ﹤0.01% | 1213 |
|
|
2020
Q1 | $333K | Sell |
3,707
-346,398
| -99% | -$31.1M | ﹤0.01% | 1181 |
|
|
2019
Q4 | $37.9M | Sell |
350,105
-21,386
| -6% | -$2.31M | 0.14% | 182 |
|
|
2019
Q3 | $36.4M | Sell |
371,491
-1,045
| -0.3% | -$102K | 0.14% | 176 |
|
|
2019
Q2 | $48.8M | Sell |
372,536
-1,937
| -0.5% | -$254K | 0.19% | 136 |
|
|
2019
Q1 | $50.6M | Buy |
374,473
+21,143
| +6% | +$2.86M | 0.3% | 97 |
|
|
2018
Q4 | $34.4M | Buy |
353,330
+2,745
| +0.8% | +$267K | 0.23% | 122 |
|
|
2018
Q3 | $48.1M | Buy |
350,585
+91,791
| +35% | +$12.6M | 0.3% | 95 |
|
|
2018
Q2 | $32.1M | Buy |
258,794
+229,676
| +789% | +$28.5M | 0.22% | 132 |
|
|
2018
Q1 | $3.25M | Buy |
29,118
+3,056
| +12% | +$341K | 0.02% | 516 |
|
|
2017
Q4 | $3.12M | Buy |
26,062
+455
| +2% | +$54.4K | 0.02% | 515 |
|
|
2017
Q3 | $3.59M | Buy |
25,607
+1,228
| +5% | +$172K | 0.03% | 483 |
|
|
2017
Q2 | $2.97M | Buy |
24,379
+9,773
| +67% | +$1.19M | 0.02% | 514 |
|
|
2017
Q1 | $1.77M | Buy |
14,606
+10,028
| +219% | +$1.22M | 0.01% | 626 |
|
|
2016
Q4 | $560K | Sell |
4,578
-7,867
| -63% | -$962K | ﹤0.01% | 895 |
|
|
2016
Q3 | $1.53M | Sell |
12,445
-8,366
| -40% | -$1.03M | 0.01% | 631 |
|
|
2016
Q2 | $2.43M | Buy |
20,811
+145
| +0.7% | +$16.9K | 0.02% | 512 |
|
|
2016
Q1 | $2.88M | Sell |
20,666
-2,863
| -12% | -$399K | 0.03% | 464 |
|
|
2015
Q4 | $4.49M | Sell |
23,529
-9,509
| -29% | -$1.81M | 0.04% | 367 |
|
|
2015
Q3 | $5.17M | Buy |
33,038
+139
| +0.4% | +$21.7K | 0.05% | 319 |
|
|
2015
Q2 | $5.95M | Buy |
+32,899
| New | +$5.95M | 0.06% | 301 |
|